Andrew Christiansen - Mar 22, 2023 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Financial Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Mar 22, 2023
Transactions value $
$0
Form type
4
Date filed
4/4/2023, 04:10 PM
Previous filing
Jan 13, 2023
Next filing
May 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock +Options Exercise $0 +8,136 +25.89% $0.00 39,561 Mar 22, 2023 Direct F1
transaction CDLX Common Stock +Options Exercise $0 +9,677 +24.46% $0.00 49,238 Apr 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Units -Options Exercise $0 -8,136 -25% $0.00 24,411 Mar 22, 2023 Common Stock 8,136 Direct F2, F3
transaction CDLX Restricted Stock Units -Options Exercise $0 -9,677 -50% $0.00 9,677 Apr 1, 2023 Common Stock 9,677 Direct F2, F3

Explanation of Responses:

Id Content
F1 Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F3 The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.